Trastuzumab beyond progression: is the risk of cardiac toxicity really not increased?
Morabito
Alessandro
A
Piccirillo
Maria Carmela
MC
De Maio
Ermelinda
E
Di Maio
Massimo
M
Perrone
Francesco
F
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans; D012307:Risk Factors; D018401:Sample Size; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab